← FDA DRUG APPROVALS

FDA ANDA · ANDA075976

METFORMIN HYDROCHLORIDE

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA075976
TYPE
ANDA
ORIGINAL APPROVAL
2002-01-24
LATEST ACTION
2019-11-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METFORMIN HYDROCHLORIDEDiscontinued
METFORMIN HYDROCHLORIDE 850MG · TABLET · ORAL
METFORMIN HYDROCHLORIDEDiscontinued
METFORMIN HYDROCHLORIDE 1GM · TABLET · ORAL
METFORMIN HYDROCHLORIDEDiscontinued
METFORMIN HYDROCHLORIDE 500MG · TABLET · ORAL

Approval history

2019-11-14Labeling · Supplement 21 · standardAP
2019-11-14Labeling · Supplement 20 · standardAP
2010-09-29Labeling · Supplement 17AP
2007-03-08Labeling · Supplement 14AP
2004-09-21Labeling · Supplement 8AP
2004-05-14Labeling · Supplement 7AP
2003-08-14Labeling · Supplement 4AP
2002-10-03Manufacturing (CMC) · Supplement 2AP
2002-04-11Labeling · Supplement 1AP
2002-01-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →